Manhard Kimberly

CIK 0001202094

EVP, Drug DevelopmentDirector

Filings

Latest Jun 4, 2026

Issuers covered

Showing

13 of 13

Page 1

Track record

2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	2	100%	+21.9%	+21.9%	+32.6%	+11.2%
90 days	2	100%	+26.5%	+26.5%	+42.3%	+10.7%
180 days	2	50%	+4.2%	+4.2%	+18.9%	-10.5%
365 days	2	100%	+75.3%	+75.3%	+99.7%	+50.9%

Companies where Manhard Kimberly has filed

Ticker	Issuer	Filings	Last filed
HRTX	Heron Therapeutics, Inc. /De/	6	Apr 17, 2023
INBX	Inhibrx Biosciences, Inc.	4	Jun 4, 2026
INBX	Inhibrx, Inc.	3	May 30, 2024

13 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jun 4, 2026	INBXInhibrx Biosciences, Inc.	Holdings only	-	-	-
May 29, 2025	INBXInhibrx Biosciences, Inc.	Holdings only	-	-	-
Aug 30, 2024	INBXInhibrx Biosciences, Inc.	PPurchase	10,000	$13.98	$139,800
May 30, 2024	INBXInhibrx Biosciences, Inc.	Holdings only	-	-	-
May 30, 2024	INBXInhibrx, Inc.	Holdings only	-	-	-
May 30, 2023	INBXInhibrx, Inc.	Holdings only	-	-	-
Apr 17, 2023	HRTXHeron Therapeutics, Inc. /De/	FTax	1,417	$2.88	$4,081
Jan 20, 2023	HRTXHeron Therapeutics, Inc. /De/	Holdings only	-	-	-
Jan 17, 2023	HRTXHeron Therapeutics, Inc. /De/	FTax	2,012	$3.17	$6,378
May 26, 2022	INBXInhibrx, Inc.	Holdings only	-	-	-
May 4, 2022	HRTXHeron Therapeutics, Inc. /De/	SSale	1,504	$4.7564	$7,154
Apr 15, 2022	HRTXHeron Therapeutics, Inc. /De/	FTax	2,012	$6.07	$12,213
Jan 14, 2022	HRTXHeron Therapeutics, Inc. /De/	FTax	2,012	$8.30	$16,700

Showing 1-13 of 13

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.